IBDENC ENCAug 10, 2023An intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adhereAn intestinal Th17 subset is associated with inflammation in Crohn's Disease and activated by adherent-invasive Escherichia coli (AIEC)...
IBDENC ENCAug 3, 2023Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis Bruce E Sands, Stefan Schreiber, Irina Blumenstein, Michael V Chiorean, Ryan C Ungaro, David T Rubin Published in July 2023, Journal of...
IBDENC ENCAug 2, 2023Inflammatory bowel disease (IBD) in rural and urban IndiaInflammatory bowel disease (IBD) in rural and urban India: results from community colonoscopic evaluation of more than 30,000 symptomatic...
IBDENC ENCMay 27, 2023The bidirectional risk of inflammatory bowel disease and anxiety or depressionThe bidirectional risk of inflammatory bowel disease and anxiety or depression: A systematic review and meta-analysis Tania H. Bisgaard,...
IBDENC ENCMay 25, 2023Identification of diagnostic biomarks and immune cell infiltration in ulcerative colitisIdentification of diagnostic biomarks and immune cell infiltration in ulcerative colitis Qin Chen, Shaosheng Bei, Zhiyun Zhang, Xiaofeng...
IBDENC ENCMay 20, 2023Performance of Cytomegalovirus Real-Time Polymerase Chain Reaction Assays of Fecal Performance of Cytomegalovirus Real-Time Polymerase Chain Reaction Assays of Fecal and Plasma Specimens for Diagnosing Cytomegalovirus...
IBDENC ENCMay 19, 2023Real-world experience with Curcumin–QingDai combination for patients with active ulcerative colitisReal-world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort...
IBDENC ENCMay 19, 2023Development of the global inflammatory bowel disease visualization of epidemiology studies Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21) Joyce W Y Mak,...
IBDENC ENCMay 16, 2023Real-World Experience With Tofacitinib Dose De-Escalation in Patients Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis Amy Yu, Nghiem B. Ha,...